	The tumor macroenvironment as cancer metabolism's next frontier. Trends Cancer Grenell AB, Rowles JL 3rd, Fowle-Grider R, Cao Y, Shriver LP, Patti GJ. PMID: 42901821 [PubMed - as supplied by publisher]
	Bispecific antibodies in NSCLC: immune reengineering to neutralize adaptive tumor resistance. Trends Cancer Li Z, Wang H, Diao M, Liu R, Wang X, Xiong A, Zhou C, Tang Z. PMID: 42901820 [PubMed - as supplied by publisher]
	Tumor innervation in non-central nervous system tumors: origins, mechanisms, and phenotypic plasticity. Trends Neurosci Zhang Y, Ye Z, Wang Y, Tang S, Chen G. PMID: 42901812 [PubMed - as supplied by publisher]
	A systematic review and meta-analysis of multi-health behavior interventions to reduce common mental health symptoms in people living with and beyond cancer. J Psychosoc Oncol Tavares VDO, Schuch FB, Skinner G, Baker T, France-Ratcliffe M, Menezes de Sousa G, Quan ML, Cuthbert C, Teychenne M. PMID: 42901772 [PubMed - as supplied by publisher]
	Observation versus maintenance immunotherapy after PD-1-induced clinical complete response in dMMR/MSI-H colorectal cancer managed non-operatively: a multicenter cohort study. J Immunother Cancer Gao X, Wang Q, Zhang Z, He F, Ding Y, Zhang L, Pei D, Niu S, Chen H, Sun R, Yao Y, Han W, Chen Y, Chang H, Xiao W, Li L, Zhang R, Gao Y. PMID: 42901720 [PubMed - in process]
	The macrophage paradox in renal AL amyloidosis: lessons from histology and imaging. Kidney Int Palladini G, Gesualdo L. PMID: 42901689 [PubMed - indexed for MEDLINE]
	Stakeholders' perspectives on communication gaps in cervical cancer prevention among women of Turkish, Moroccan and Syrian origin: a focus group study in the Netherlands. BMJ Open Veeravagu T, Hamdiui N, Stein ML, Al-Rubaie NHS, Van Wijk JLI, Bouman MPA, Crutzen R, Timen A. PMID: 42901579 [PubMed - in process]
	Evaluating [(18)F]-AlF-FAPI-74 PET/CT for diagnosis of the unfavourable CMS4 colorectal cancer subtype (FoCus study): protocol for a prospective, observational, proof-of-concept clinical study. BMJ Open van Duijvenvoorde M, Kranenburg O, van den Bos M, Hagendoorn J, Roodhart JML, Milne AN, Te Riele WW, Lange MM, Swijnenburg RJ, Arensman R, Verheijen PM, Schiphorst AHW, Kool W, Ververs T, De Keizer B, Lacle MM, Lam MGEH, Elias SG. PMID: 42901570 [PubMed - in process]
	Associations Between Tumor-Left Brachiocephalic Vein Distance and Operative Time in Minimally Invasive Subxiphoid Surgery for Thymoma. Asian J Endosc Surg Kimura T, Miyashita Y, Nagata H, Kimura K, Kanou T, Ose N, Shintani Y. PMID: 42901539 [PubMed - indexed for MEDLINE]
	Hepatic Cysts in Korea: Prevalence, Incidence, and Risk Factors Based on a 5.8-Year Follow-up Health Screening Cohort. J Korean Med Sci Seo K, Kim Y, Park SH, Yi NJ, Yoon JH, Chung GE, Lee JM, Rho SY, Park MS, Choe EK, Shin A. PMID: 42901497 [PubMed - indexed for MEDLINE]
	Radiolabelled cyclodextrins to detect cervical cancer: a preclinical feasibility study. Eur J Pharm Sci Szita DB, Béres E, Szabó JP, Dienes RA, Heged, Szegedi K, Jóna Á, Forgács L, Opposits G, Jószai I, Fekete A, Fenyvesi F, Hajdu I, Papp T, Mészár Z, Árkosy P, Kertész I, Képes Z, Trencsényi G. PMID: 42901454 [PubMed - as supplied by publisher]
	AMPK signaling in cancer: Molecular insights and therapeutic opportunities. Cancer Lett Jiang W, Yan P, Wang J, Xue X, Huang D, Chen L, Yang Y, Inuzuka H, Wei W. PMID: 42901439 [PubMed - as supplied by publisher]
	Spatial Plasticity and Multidirectional Crosstalk of Cancer-Associated Adipocytes in Therapy-Remodeled Niches. Cancer Lett Xie J, Cai T, Wang N, Zhang W, Zhong S, Qian H, Liu Y, Ye D, Wang Z, Tang H. PMID: 42901438 [PubMed - as supplied by publisher]
	Next-Generation CAR-Macrophage Therapies: Design Principles and Advances in Cancer Treatment. Cancer Lett Wang W, Guo S, Chu Q, Yu Q, Romero M, Shi X, Shan S, Gao C, Fu S, Ren H. PMID: 42901433 [PubMed - as supplied by publisher]
	Engineering whole tumor cell vaccines for cancer immunotherapy: From malignant cells to therapeutic vaccines. J Control Release Wu C, Xia Z, Huang L, Huang J, Zhu W, Chen Y. PMID: 42901394 [PubMed - as supplied by publisher]
	Brief Report: Characterization of the Potentially Actionable TP53 Y220C Mutation in Non-Small Cell Lung Cancer. A Multicenter, European Thoracic Oncology Platform Study. J Thorac Oncol Molina-Vila MA, Tsourti Z, Stenzinger A, Thüsen JV, Hillen LM, Hofman P, Rahmani-Khajouei S, Hegedüs B, Radonic T, Bubendorf L, Madsen LB, Pokharel S, Jordana-Ariza N, Kazdal D, Speel EM, Hendriks LEL, Hofman V, Zoche M, Bölükbas S, Bahce I, Kashima J, Rosell R, Peters S, Kammler R, Dafni U, Finn SP, Stahel RA. PMID: 42901386 [PubMed - as supplied by publisher]
	From Blue Dye to Multimodal-Guided Surgery: The Evolution of Sentinel Lymph Node Mapping in Vulvar Cancer - A Narrative Review. Crit Rev Oncol Hematol D'Angelo G, Ascione M, Palumbo M, Garganese G, Fragomeni SM, Bifulco G, Corte LD. PMID: 42901335 [PubMed - as supplied by publisher]
	Context Is Everything: Tumour-Type-Dependent Prioritisation of Tumour-Intrinsic, Microenvironmental and Host Determinants of Response to Immune-Checkpoint Blockade. Crit Rev Oncol Hematol Wu Y, Fan W. PMID: 42901334 [PubMed - as supplied by publisher]
	The evolution of immunotherapy resistance in mismatch repair-deficient colorectal cancer: A spatiotemporal perspective. Crit Rev Oncol Hematol Lv Y, Ding Y, Zhao Z, Song S, Zang D, Zhang J, Ji Y, Zhong J. PMID: 42901333 [PubMed - as supplied by publisher]
	CXC chemokines as context-dependent regulators of immunity, homeostasis and cancer. Cell Signal Miralles CM, Manousakis E, Moreta-Moraleda C, Wright RHG. PMID: 42901286 [PubMed - as supplied by publisher]

Articles 1 - 20 / 1982443

Page 1 of 99123



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy